Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2667-2671

  Cheah, A L Y ^a   Spelman, T ^a,b   Peel, T ^c   Howden, B P ^d   Spelman, D ^e   Grayson, M L ^d   Nation, R L ^a   Kong, D C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTIN HEALTH   (Australia)

^e The Alfred   (Australia)

Author keywords

Antibiotic resistance; bacterial infections; Enterococcus; epidemiology

Indexed keywords

ARTICLE; BACTERIAL GENE; CHARLSON COMORBIDITY INDEX; CHILD; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; QUANTITATIVE ANALYSIS; SURVIVAL RATE; VANB GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN SUSCEPTIBLE ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; BACTEREMIA; CROSS INFECTION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVAL;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; FEMALE; HUMANS; LENGTH OF STAY; MALE; SURVIVAL ANALYSIS; VANCOMYCIN RESISTANCE; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84911484659     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881400020X     Document Type: Article

References (10)

1. Butler AM, et al. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infection Control and Hospital Epidemiology 2010; 31: 28-35.
2. Cheah ALY, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clinical Microbiology and Infection 2013; 19: E181-189.
3. Forster AJ, et al. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. Canadian Medical Association Journal 2012; 184: 37-42.
4. van Walraven C, et al. Time-dependent bias was common in survival analyses published in leading clinical journals. Journal of Clinical Epidemiology 2004; 57: 672-682.
5. Beyersmann J, et al. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. Journal of Clinical Epidemiology 2008; 61: 1216-1221.
6. Australian Group for Antimicrobial Resistance (AGAR) Posters and Publications. Vancomycin resistant enterococci in Australia: results of the AGAR surveys 1995 to 2010 (http://www.agargroup.org/files/VRE%20in% 20Australia.pdf). Accessed 30 August 2013.
7. Bone R, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
8. Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373-383.
9. Austin P, Rothwell D, Tu J. A comparison of statistical modeling strategies for analyzing length of stay after CABG surgery. Health Services and Outcomes Research Methodology 2002; 3: 107-133.
10. McGreevy KM, et al. Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data. Clinical Chemistry 2009; 55: 165-169.